Franco Negron Segarra is Senior Advisor to the Chairman of ApiJect, where he helps guide the company’s partnerships with leading pharmaceutical, biotech, and manufacturing service companies.
Mr. Negron’s experience in the pharmaceutical industry spans nearly 25 years. Previously, he served most recently as President of Commercial Operations of Thermo Fisher Scientific. Earlier posts with Themo Fisher included serving as President, TFS Drug Product Services and Product Development Services North America, following TFS’s acquisition of Patheon Pharmaceuticals. He joined Thermo-Fisher in 2017 when it acquired his previous employer, Patheon Pharmaceuticals, where he served as President of Development & Commercial, North America. Shortly after the acquisition he was named President of Commercial Operations for the newly formed Pharma Services Group. Prior to his post at Patheon, Mr. Negron was Vice President of Manufacturing and Supply at Valeant Pharmaceuticals, Global Vice President in Novartis’ Consumer Health Over-the-Counter and Pharmaceutical Products Division, and Site General Manager at McNeil Consumer Healthcare.